STAT NewsTempus unveils prototype cube that talks back to oncologistsJan 11, 2021Clinical TrialsProduct LaunchMedia CoverageRelated contentTempus Announces the Clinical Launch of its Immune Profile Score Algorithmic TestTempus Announces the Clinical Launch of its MRD Testing PortfolioTempus Introduces xM MRD to Assess Minimal Residual Disease (MRD) in Patients with Colorectal Cancer (CRC) for Research Use Only